Alterations in expression of sarcoplasmic reticulum gene in dahl rats during the transition from compensatory myocardial hypertrophy to heart failure

Journal of Hypertension

Volumn 15, Issue 12, 1997, Pages 1767-1774

  Okayama, Hideki ^a   Hamada, Mareomi ^a   Kawakami, Hideo ^a   Ikeda, Syuntaro ^a   Hashida, Hidetoshi ^a   Shigematsu, Yuji ^a   Hiwada, Kunio ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dahl rat; Left ventricular hypertrophy; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALSEQUESTRIN; MESSENGER RNA; PHOSPHOLAMBAN; RYANODINE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SARCOPLASMIC RETICULUM;

EID: 0031445058     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199715120-00087     Document Type: Article

References (35)

1. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K: Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995, 13:155-160.
2. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, et al.: The heart in hypertension. N Engl J Med 1992, 327:998-1008.
3. Fouad FM, Slominski JM, Tarazi RC: Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984, 3:1500-1506.
4. Hamada M, Ohtani T, Suzuki M, Lin M, Kobayashi T, Okayama H, et al.: Is left ventricular systolic dysfunction in hypertensive patients with heart failure normalized by long-term antihypertensive therapy? J Cardiol 1993, 23:165-175.
5. Feldman AM, Weinberg EO, Ray PE, Lorell BH: Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993, 73:184-192.
6. Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, et al.: The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 1995, 27:383-396.
7. Iwai J, Heine M: Dahl salt-sensitive rats and human essential hypertension. J Hypertens 1986, 4 (suppl 3):S29-S31.
8. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S: Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 1994, 267:H2471-H2482.
9. Lytton J, MacLennan DH: Sarcoplasmic reticulum. In The Heart and Cardiovascular System. Edited by Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE. New York: Raven Press; 1992:1203-1222.
10. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M: Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1993, 72: 463-469.
11. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, et al.: Abnormal calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987, 61:70-76.
12. Kawakami H, Okayama H, Hamada M, Hiwada K: Alteration of atrial natriuretic and brain natriuretic peptide gene expression associated with progression and regression of cardiac hypertrophy in renovascular hypertensive rats. Clin Sci 1996, 90:197-204.
13. 2+ -ATPase gene. Circ Res 1992, 71:9-17.
14. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS: Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995, 91:2642-2654.
15. Sahn DJ, DeMaria A, Kisslo J, Weyman A, the committee of M-mode standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
16. Okayama H, Hamada M, Hiwada K: Contractile dysfunction in the diabetic-rat heart is an intrinsic abnormality of the cardiac myocyte. Clin Sci 1994, 86:257-262.
17. Douglas PS, Reichek N, Plappert T, Muhammad A, St John Sutton MG: Comparison of echocardiographic methods for assessment of LV shortening and wall stress. J Am Coll Cardiol 1987, 9:945-951.
18. 2+ -ATPase mRNA. FEBS Lett 1989, 249:35-41.
19. Ganim JR, Luo W, Ponniah S, Grupp I, Kim HW, Ferguson DG, et al.: Mouse phospholamban gene expression during development in vivo and in vitro. Circ Res 1992, 71:1021-1030.
20. Scott BT, Simmerman HKB, Collins JH, Nadal-Ginard B, Jones LR: Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem 1988, 263:8958-8964.
21. 2+ release channel (ryanodine receptor) of rabbit cardiac muscle sarcoplasmic reticulum. J Biol Chem 1990, 265:13472-13483.
22. Brillantes AM, Bezprozvannaya S, Marks AR: Developmental and tissue-specific regulation of rabbit skeletal and cardiac muscle calcium channels involved in excitation-contraction coupling. Circ Res 1994, 75:503-510.
23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
24. 2+ ATPase and decreasing phospholamban expression. J Mol Cell Cardiol 1994, 26:1145-1154.
25. 2+ -ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990, 66:554-564.
26. 2+ -dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage. J Clin Invest 1989, 83:1102-1108.
27. Matsui H, MacLennan DH, Alpert NR, Periasamy M: Sarcoplasmic reticulum gene expression in pressure overload-induced cardiac hypertrophy in rabbit. Am J Physiol 1995, 268:C252-C258.
28. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, et al.: Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res 1994, 75:23-32.
29. 2+ -ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ Res 1991, 69:1380-1388.
30. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW II, Walsh RA, et al.: Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice. J Clin Invest 1996, 97:533-539.
31. 2+ transport and myocardial relaxation. Circ Res 1994, 75:245-251.
32. Brillantes AM, Allen P, Takahashi T, Izumo S, Marks AR: Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 1992, 71:18-26.
33. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, et al.: Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995, 92:778-784.
34. 2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy. Circulation 1992, 85:518-525.
35. Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, Obata K, et al.: Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987, 76:115-124.